<?xml version="1.0" encoding="UTF-8"?>
<norine>
    <peptide>
        <contributor>
            <name>Norine team</name>
            <affiliations>
                <affiliation>ProBioGEM (UPRES EA 1026 USTL), France</affiliation>
                <affiliation>LIFL (UMR CNRS 8022 / Univ. Lille1), France</affiliation>
            </affiliations>
        </contributor>
        <cite>Please cite Norine: a database of nonribosomal peptide, Caboche et Al., Nucleic Acids Research 2008; 36:D326-D331</cite>
        <general>
            <id>NOR00005</id>
            <name>A54145 F</name>
            <family>A54145</family>
            <activities>
                <activity>antibiotic</activity>
            </activities>
            <category>lipopeptide</category>
            <formula>C71H107N17O27</formula>
            <mw>1630.707</mw>
            <comment>A54145 products are antibiotics for the traitment of infections caused by gram-positive pathogens.</comment>
            <status>curated</status>
        </general>
        <structure>
            <type>partial cyclic</type>
            <size>14</size>
            <composition>iC10:0, Trp, D-Glu, OH-Asn, Thr, NMe-Gly, Ala, Asp, D-Lys, OMe-Asp, Gly, D-Asn, Glu, Val</composition>
            <graph>iC10:0,Trp,D-Glu,OH-Asn,Thr,NMe-Gly,Ala,Asp,D-Lys,OMe-Asp,Gly,D-Asn,Glu,Val@1@0,2@1,3@2,4@3,5,13@4,6@5,7@6,8@7,9@8,10@9,11@10,12@11,13@4,12</graph>
        </structure>
        <organisms>
            <organism>
                <name>Streptomyces fradiae</name>
                <taxonomy>cellular organisms, Bacteria, Actinobacteria, Actinobacteria, Actinobacteridae, Actinomycetales, Streptomycineae, Streptomycetaceae, Streptomyces</taxonomy>
                <gram>positive</gram>
                <synonym>Streptomyces roseoflavus,Streptomyces fradii,Actinomyces fradii,Streptomyces roseiflavus</synonym>
                <taxid>1906</taxid>
            </organism>
        </organisms>
        <references>
            <reference>
                <title>Natural products to drugs: daptomycin and related lipopeptide antibiotics</title>
                <year>2005</year>
                <journal>Natural product reports</journal>
                <location>Dec,22(6):717-41. Epub 2005 Nov 4.</location>
                <pmid>16311632</pmid>
                <authors>
                    <author>
                        <name>Baltz RH</name>
                    </author>
                    <author>
                        <name>Miao V</name>
                    </author>
                    <author>
                        <name>Wrigley SK</name>
                    </author>
                </authors>
            </reference>
            <reference>
                <title>Biosynthesis and genetic engineering of lipopeptide antibiotics related to daptomycin</title>
                <year>2008</year>
                <journal>Current topics in medicinal chemistry</journal>
                <location>8(8):618-38</location>
                <pmid>18473888</pmid>
                <authors>
                    <author>
                        <name>Baltz RH</name>
                    </author>
                </authors>
            </reference>
        </references>
        <links>
            <link>
                <acc>Q45R82</acc>
                <name_db>UniProt</name_db>
            </link>
            <link>
                <acc>Q45R83</acc>
                <name_db>UniProt</name_db>
            </link>
            <link>
                <acc>Q45R84</acc>
                <name_db>UniProt</name_db>
            </link>
            <link>
                <acc>Q45R85</acc>
                <name_db>UniProt</name_db>
            </link>
        </links>
    </peptide>
</norine>